| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.1M | +3.5% | -0.8% |
| Cost of Revenue | $532K | +0.9% | -1.7% |
| R&D Expense | $3.7M | +12.0% | -9.5% |
| SG&A Expense | $4.1M | -12.5% | +9.5% |
| Operating Income | -$7.2M | +9.6% | +0.3% |
| Interest Expense | $6K | +140.0% | +103.7% |
| Pre-tax Income | -$9.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.5M | +59.8% | -73.4% |
| Accounts Receivable | $1.4M | +22.5% | +15.1% |
| Inventory | $10.6M | -0.8% | +9.9% |
| Current Assets | $29.4M | +5.4% | -19.8% |
| Total Assets | $49.5M | +2.5% | -15.4% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$18.2M | — | — |
| Capital Expenditures | $16K | — | — |
| Investing Cash Flow | -$54K | — | — |
| Financing Cash Flow | $13.9M | — | — |
| Free Cash Flow | -$18.2M | — | — |
| +8.6% |
| +3.7% |
| Net Income | -$9.5M | +8.7% | +3.6% |
| EPS (Basic) | -$6.28 | +38.8% | -498.1% |
| EPS (Diluted) | -$6.28 | +38.8% | -498.1% |
| $36.1M |
| +23.6% |
| +81.8% |
| Total Liabilities | $45.1M | +9.0% | +5.2% |
| Stockholders' Equity | $4.4M | -36.6% | -66.7% |